MechanismsTherapeuticsCancer Drug ResistanceNeurodegenerative
Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment
Cell Death Discovery 2025-04-21
Xinyi Yang, Yingchao Liu, Jun Xia, Jing Du
Abstract
NRF2 is regulated through post-translational modifications (PTMs) and epigenetic alterations. PTMs including phosphorylation, ubiquitination, and acetylation modulate NRF2's stability, activity, and localization. Epigenetic modifications including DNA methylation, histone modifications, and non-coding RNAs regulate NRF2 expression.
Key Findings
- NRF2 stability controlled by phosphorylation, ubiquitination, acetylation
- Epigenetic modifications regulate NRF2 expression
- DNA methylation of NRF2 promoter represses expression
- Roadmap for PTM-targeted NRF2 therapies
Clinical Significance
Opens new therapeutic dimensions by mapping complete regulatory landscape of NRF2.
Citation
Yang, X. et al. (2025). Epigenetic and PTM modifications of NRF2. Cell Death Discovery.
DOI: 10.1038/s41420-025-02491-z